BioPharm America™: Interview with Jeremy Levin, Ovid Therapeutics

September 24, 2015
Joe Haas from “The Pink Sheet” interviewed Ovid Therapeutics CEO Jeremy Levin, formerly with Bristol-Myers Squibb and most recently the CEO of Teva Pharmaceuticals. They discussed the trend of big pharma brainpower moving to smaller firms to enable them to spend more time on innovation, without some of the distractions attendant in working at a large pharma company.
Previous Video
BIO-Europe® 2015: Interview with Don O'Sullivan, Genentech Partnering
BIO-Europe® 2015: Interview with Don O'Sullivan, Genentech Partnering

Most likely when you think of Genentech, you think "oncology." But, Genentech also has a thriving presence ...

Next Video
BioPharm America™: Interview with Baiju Shah, BioMotiv
BioPharm America™: Interview with Baiju Shah, BioMotiv

Joe Haas from “The Pink Sheet” interviewed Baiju Shah, CEO of BioMotiv, an accelerator of biotechnological ...